Belantamab mafodotin is under clinical development by GSK and currently in Phase I for Systemic Lupus Erythematosus.

CCAR-168 is under clinical development by AbelZeta and currently in Phase I for Lupus Nephritis. According to GlobalData, Phase I drugs for Lupus Nephritis have an 84% phase transition success rate ...

Atherosclerosis progression was more than twice as common in younger people with systemic lupus erythematosus (SLE) than in ...

Jone Naikabula enjoyed a day to remember on the right wing, crossing the line twice in the second half to extend the lead for ...

"Incomplete lupus" is a term used to describe a person who has some symptoms of lupus but not enough to make the diagnosis ...

For the first time, Selena Gomez is being recognized by the Golden Globes for her work in film. The actress has been ...

Nick Cannon opened up about his lupus diagnosis during a new house tour of his ‘Cannon Estate,’ comparing his lupus journey to Tony Stark’s life while showing off his Louis Vuitton Iron Man helmet.

CAR-T cell therapy, a marvel of bioengineering, takes a patient’s own immune cells and reprograms them to attack cells causing Lupus. First approved for treating leukemia in 2017, CAR-T cell therapy ...

The prevalence of fibromyalgia is higher among patients with SLE vs the general population, adding to an already significant ...

The link between lupus and bipolar disorder is complex and can lead to misdiagnosis. Learn how to recognize the symptoms of ...

Seta Tamanivalu marked his 50th appearance for Brave Lupus Tokyo with the opening try Sunday as the defending champions held ...

Lupus warriors were treated to a makeup tutorial and demo, which aimed to uplift and empower them to continue to shine ...